Wealthcare Advisory Partners’s Maxim Integrated Products MXIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,407
Closed -$129K – 2095
2021
Q1
$129K Buy
+1,407
New +$129K 0.01% 594
2020
Q2
– Sell
-1,418
Closed -$69K – 1498
2020
Q1
$69K Buy
1,418
+2
+0.1% +$115 0.01% 449
2019
Q4
$87K Buy
1,416
+3
+0.2% +$175 0.01% 428
2019
Q3
$82K Buy
1,413
+799
+130% +$46.3K 0.01% 438
2019
Q2
$37K Buy
614
+2
+0.3% +$114 0.01% 577
2019
Q1
$33K Sell
612
-227
-27% -$12.2K 0.01% 553
2018
Q4
$43K Sell
839
-31
-4% -$1.62K 0.01% 463
2018
Q3
$49K Buy
870
+2
+0.2% +$121 0.01% 479
2018
Q2
$51K Sell
868
-69
-7% -$4.02K 0.01% 461
2018
Q1
$56K Sell
937
-486
-34% -$28.8K 0.01% 381
2017
Q4
$74K Buy
1,423
+719
+102% +$37.4K 0.02% 310
2017
Q3
$34K Buy
+704
New +$32.3K 0.01% 359

Other funds holding MXIM

Wealthcare Advisory Partners's MXIM Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Maxim Integrated Products (MXIM) in Q2 2021, closing a stake of 1,407 shares — an estimated $129K sold.

Wealthcare Advisory Partners first reported a position in MXIM in Q3 2017 and held it in 12 quarters. The position peaked at $129K in Q1 2021. 622 funds tracked by Wall St. Rank hold MXIM as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Maxim Integrated Products position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1,407 Maxim Integrated Products shares in Q2 2021, an estimated $129K.
  • Wealthcare Advisory Partners first reported a position in Maxim Integrated Products in Q3 2017 and held it in 12 quarters.
  • Wealthcare Advisory Partners's Maxim Integrated Products position peaked at $129K in Q1 2021.
  • 622 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.